References

  1. Hubbard J. Megaloblastic and non-megaloblastic macrocytic anemias: in clinical laboratory hematology. Ed: Mc Kenzie SB. 2003; 263-288.

  2. Whitehead VM, Rosenblatt DS, Cooper BA. Megaloblastic anemia. In hematology of infancy and childhood (Eds: Nathanand Oski). Sixth Edition WB Saunders Co. 2003; 419-456.

  3. Lanskovsky P. Classification and diagnosis of anemia in children. In: P. Lanskovsky (ed). Manual of paediatric hematology and oncol, 5th ed, Academic Press, London, 2011:1-86. Google Scholar

  4. Savage DG, Ogundipe A, Allen RH, Stabler SP, Lindenbaum J. Etiology and diagnostic evaluation of macrocytosis. Am J Med Sci. 2000; 319(6): 343-352. PubMed | Google Scholar

  5. Aslinia F, Mazza JJ, Yale SH. Megaloblastic anemia and other causes of macrocytosis. Clin Med Res. 2006; 4(3): 236-241. PubMed | Google Scholar

  6. Colon-Otero G, Menke D, Hook CC. A practical approach to the differential diagnosis and evaluation of the adult patient with macrocytic anemia. Med Clin North Am. 1992; 76(3):581-597. PubMed | Google Scholar

  7. Pappo AS, Fields BW, Buchanan GR. Etiology of red blood cell macrocytosis during childhood: impact of new diseases and therapies. Paediatrics. 1992 Jun; 89(6Pt 1): 1063-106. PubMed | Google Scholar

  8. Herminston ML, Mentzer WC. A practical approach to the evaluation of the anemic child. Pediatr Clin North Am. 2002 Oct; 49(5): 877-91. PubMed | Google Scholar

  9. David O, Fiorucci GC, Tosi MT, Altare F, Valori A, Saracco P et al. Hematological studies in children with Down syndrome. Paediatric Hematology Oncology. 1996; 13(3): 271-275. PubMed | Google Scholar

  10. Prasher VP. Screening of medical problems in adults with Down syndrome. Down Syndrome Research and Practice. 1994; 2(2): 59-66. Google Scholar

  11. Bruwier A, Chantrain CF. Hematological disorders and leukemia in children with Down syndrome. Eur J Pediatr. 2012 Sep; 171(9): 1301-1307. PubMed | Google Scholar

  12. Shimamura A, Nathan DG. Acquired aplastik anemia and purered cell aplasia. In Nathan DG, Orkin SH, Ginsburg D, Look AT, Fisher DE, Lux SE (eds). Nathan and Oski’s Hematology of infancy and childhood, 7th ed. Philadelphia, WB Saunders, 2009; 275-305. Google Scholar

  13. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF et al. A 20-years perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003; 101(4): 1249-1256. Google Scholar

  14. Wartenberg GF, Adelman AS. Acute lymphoblastic leukemia: Epidemiology and etiology. In: Estey EH, Faderl SH, Kantarjian H (eds), Hematologic Malignancies: Acute Leukemias. Berlin Heidelberg. 2008; 77-95. Google Scholar

  15. Maligne S, Izraeli S, Crispino JD. Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood. 2009; 113(12): 2619-2628. PubMed | Google Scholar

  16. Hasle H, Clemmensen IH, Mikkelsen M. Risks of leukemia and solid tumours in individuals with Down's syndrome. Lancet. 2000; 355(9199): 165-169. Google Scholar

  17. Buitenkamp TD, Izraeli S, Zimmermann M, Forestier E, Heerema NA, van den Heuvel-Ei-brink MM et al. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Pontedi Legno study group. Blood. 2014; 123(1):70-77. PubMed | Google Scholar

  18. Webb D, Roberts I, Vyas P. Haematology of Down syndrome. Arch Dis Child Fetal Neonatal Ed. 2007; 92(6): F503-F507. PubMed | Google Scholar

  19. Zeller B, Gustafsson G, Forestier E, Abrahamsson J, Clausen N, Heldrup J et al. Acute leukaemia in children with Down syndrome: a population-based Nordic study. Br J Haematol. 2005; 128:797-804. PubMed | Google Scholar

  20. Talsma CE, Boyer DF. Myeloid leukemia associated with Down syndrome. Blood. 2017; 130(2): 230. PubMed | Google Scholar